Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

FDA approves supplemental BLA for Gazyva

Dec. 30, 2014

Kite Pharma submits IND application for phase I/II trial of KTE-C19

Dec. 29, 2014

First U.S. approval granted for nivolumab injection for metastatic melanoma

Dec. 23, 2014

NETRIS Pharma creates first humanized monoclonal antibody against netrin-1

Dec. 23, 2014

Inovio Pharmaceuticals begins DNA immunotherapy trial for breast, lung and pancreatic cancer

Dec. 23, 2014

Kyowa Hakko Kirin receives additional indication approval for Poteligeo in Japan

Dec. 22, 2014

Preliminary phase I/IIa data for an anticancer vaccine against multiple myeloma

Dec. 18, 2014

Preclinical data for RG-7888 support phase I investigation

Dec. 18, 2014

Prima BioMed initiates pilot trial of CVac in pancreatic cancer

Dec. 18, 2014

Activity of fully human bispecific antibody against B-cell lymphoma described

Dec. 17, 2014

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...